Oyster Point Pharma, Inc. Accrued Liabilities, Current
Oyster Point Pharma, Inc. had Accrued Liabilities, Current of $24.36 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-10
- 2022-09-30: Accrued Liabilities, Current $24.36M.
- 2022-06-30: Accrued Liabilities, Current $25.70M.
- 2022-03-31: Accrued Liabilities, Current $19.71M.
- 2021-12-31: Accrued Liabilities, Current $21.51M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-09-30 | $24.36M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $25.70M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $19.71M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $21.51M 10-Q · filed 2022-11-10 | |
| 2021-09-30 | $11.17M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $6.59M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.11M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $8.29M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $6.75M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.53M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.48M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.60M 10-K · filed 2021-02-18 | $4.60M 10-K · filed 2020-02-27 |
| 2019-09-30 | $3.46M 10-Q · filed 2019-12-03 | |
| 2018-12-31 | $422.00K 10-K · filed 2020-02-27 |